Skip to content
Screener

Scholar Rock SRRK Free cash flow margin

Discontinued — last reported Q1 '22

Free cash flow margin at other companies

Biogen logo
BiogenBIIB
26.9%+7.1pp
PTC Therapeutics logo
PTC TherapeuticsPTCT
39.1%+32.8pp
CalAmp logo
CalAmpCAMP
-1,254%—

Other financials

Income statement

See full
Revenue-—
Operating income-$108.9M+2.9%
Net income-$109.9M+0.1%
EPS (diluted)-$0.84+14.3%

Balance sheet

See full
Cash & equivalents$437.1M+186%
Total debt$203.8M+231%
Total equity$253.8M+8.8%
Total assets$523.5M+54.0%

Cash flow

See full
Operating cash flow-$70.3M+8.6%
CapEx$1.0K-99.5%
Free cash flow-$70.3M+8.9%

Valuation

See full
Market cap$6.41B+92.7%
Enterprise value$6.18B+90.9%

Profitability

See full
Operating margin-231.8%—
Net margin-236.9%—

Returns & leverage

See full
Return on equity-167.8%-4.1pp
Debt / equity0.8×+0.5×
Current ratio7×+0.7×

Where this comes from

Calculated from Scholar Rock’s reported figures.

free cash flow/total revenue=-309.1%

Based on trailing twelve months.

The source filing: Scholar Rock’s 10-Q, filed May 9, 2023. Open the filing →

Filed
May 9, 2023
Fiscal quarter
Q1 FY2023
Calendar quarter
Q1 2023
Accession
0001558370-23-008674

FAQ

What is Scholar Rock's free cash flow margin?
Scholar Rock (SRRK) reported free cash flow margin of -309.1% in Q1 2022.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Ask your AI about Scholar Rock's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude